Nathan Sackett, MD, MS, is an addiction psychiatrist and Acting Assistant Professor in the University of Washington Department of Psychiatry & Behavioral Sciences. Clinically, he works with patients who struggle with both primary psychiatric disorders and substance use disorders primarily in a busy academic outpatient clinic. Nathan is also the co-director of the Center for Novel Therapeutics in Addiction Psychiatry, a translational research center focusing on examining psychedelics as augmenting agents of behavioral interventions to treat addiction. Nathan is the Principal Investigator of a Washington-state funded clinical trial exploring the use of psilocybin in high-risk patient populations.